search
Back to results

Effect of Physical Exercise in Alzheimer Patients (ADEX)

Primary Purpose

Alzheimer Disease

Status
Completed
Phase
Phase 3
Locations
Denmark
Study Type
Interventional
Intervention
Aerobic exercise
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alzheimer Disease focused on measuring Alzheimer Disease, Exercise, Cognition, Quality of life, Cardiovascular fitness, Behavioural or psychological symptoms, Physical fitness

Eligibility Criteria

50 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Inclusion criteria are (table 1)
  • Age between 50 and 90 years
  • A score of 20 or more on the Mini Mental State Examination (MMSE)
  • Imaging (CT or MR of cerebrum) consistent with AD
  • Have a caregiver with regular contact to the participant (more than once a month) who is also willing to participate in the study
  • In general good health allowing the participant to participate in physical exercise.
  • At least 7 years of schooling and Danish speaking
  • Visual acuity and hearing must permit neuropsychological testing.
  • If the patient is receiving anti-dementia medication or mood stabilizing medication, these must have been given in stable doses for at least 3 months.

Exclusion Criteria:

  • Participation in aerobic exercise (moderate to hard intensity) more than 2 times a week on a regular basis.
  • Any musculoskeletal or joint impairment that could interfere with completion of the study (significant joint problems, back pain or pain in arms and legs that provide problems with mobility in daily activities)
  • Male participants with a combination of two or more of the following risk factors even if asymptomatic: smokers, hypertension and hypercholesterolemia
  • Major neurologic (other than AD), cardiac or other medical diseases that constitutes a contraindication to physical activity. Stent operation or previous myocardial infarction is not an exclusion criteria if the participant has had a recent (within 3 months) normal exercise tests .
  • Severe cerebro vascular disease judged from the CT or MR scans and remarkable hypertension defined as Systolic blood pressure >180 and diastolic >100
  • Severe psychiatric disease, as well as alcohol or drug abuse within the last 2 years

Sites / Locations

  • Danish Dementia Research Centre, Department of Neurology, Rigshospitalet.

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Intervention group

Control group

Arm Description

16 weeks of aerobic exercise

Usual care.

Outcomes

Primary Outcome Measures

Symbol Digit Modalities Test

Secondary Outcome Measures

NPI (psychological symptoms.)
Astrand submaximal bicycle test for estimating VO2 max
Euro-qol-5D-5L (health related quality of life)
Alzheimer's disease Assessment Scale - Cognitive section (ADAS-cog).
Changes in physical fitness
Timed up and go test (TUG), 10 m walk, 10m Dual-Task, 400m fast walking, Sit-to-stand (number in 30 sec.)(STS).
Self-efficacy scale
Verbal fluency
Stroop
MMSE (Mini Mental State Examination)

Full Information

First Posted
April 30, 2012
Last Updated
November 28, 2014
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT01681602
Brief Title
Effect of Physical Exercise in Alzheimer Patients
Acronym
ADEX
Official Title
Preserving Quality of Life, Physical Health and Functional Ability in Alzheimer's Disease: The Effect of Physical Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
November 2014
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
June 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background: Current treatment for Alzheimer's disease (AD) is symptomatic and can only temporarily slow down progression. Exercise has the potential to improve cognition, psychological symptoms, physical performance and quality of life, but evidence is scarce. Previous trials are short, often underpowered and involving home based light exercise programs. Most have included nursing homes residents with severe or undefined dementia. The aim of the ADEX trial is to establish whether exercise is effective in improving cognition, physical performance and quality of life as well as reducing the prevalence of psychological symptoms among AD patients. Methods: The ADEX Trial is a multicentre, single-blind, randomized clinical trial. Based on power calculations the investigators plan to recruit 192 home-dwelling patients aged 50-90 years with mild to moderate AD. The participants will be randomly allocated into two groups: An intervention group attending 16 weeks of continuously supervised moderate aerobic exercise 1 hour three times a week and a control group only receiving usual care. The hypothesis is that aerobic exercise will improve physical function, the cognitive and daily functioning and quality of life in people with mild to moderate AS. Blood sampling will be performed in all subjects to examine effects on biomarkers. A subgroup of the patients will also undergo MRI, PiB-PET and lumbar puncture to investigate structural changes and β-amyloid accumulation. Further, a health-economic analysis will be performed. Recruitment was started in January 2012. Last study visits are planned to be performed in January 2014 and results will be available in 2014. This RCT will contribute to evidence regarding the potential effects of a systematic program of physical exercise for patients with Alzheimer's disease.
Detailed Description
see protocol article

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease
Keywords
Alzheimer Disease, Exercise, Cognition, Quality of life, Cardiovascular fitness, Behavioural or psychological symptoms, Physical fitness

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Active Comparator
Arm Description
16 weeks of aerobic exercise
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Usual care.
Intervention Type
Other
Intervention Name(s)
Aerobic exercise
Other Intervention Name(s)
Endurance training
Intervention Description
Physical exercise in the intervention group will be delivered as an individually tailored program consisting of 4 weeks of adaptation exercise followed by 12 weeks of continuously supervised moderate aerobic exercise 1 hour three times a week. The participants can choose from treadmill, stationary bike and crosstrainer.
Primary Outcome Measure Information:
Title
Symbol Digit Modalities Test
Time Frame
Change in score from baseline to 16 weeks
Secondary Outcome Measure Information:
Title
NPI (psychological symptoms.)
Time Frame
Change in score from baseline to 16 weeks
Title
Astrand submaximal bicycle test for estimating VO2 max
Time Frame
Change in score from baseline to 16 weeks
Title
Euro-qol-5D-5L (health related quality of life)
Time Frame
Change in score from baseline to 16 weeks
Title
Alzheimer's disease Assessment Scale - Cognitive section (ADAS-cog).
Time Frame
Change in score from baseline to 16 weeks
Title
Changes in physical fitness
Description
Timed up and go test (TUG), 10 m walk, 10m Dual-Task, 400m fast walking, Sit-to-stand (number in 30 sec.)(STS).
Time Frame
Change in score from baseline to 16 weeks
Title
Self-efficacy scale
Time Frame
Change in score from baseline to 16 weeks
Title
Verbal fluency
Time Frame
Change in score from baseline to 16 weeks
Title
Stroop
Time Frame
Change in score from baseline to 16 weeks
Title
MMSE (Mini Mental State Examination)
Time Frame
Change in score from baseline to 16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Inclusion criteria are (table 1) Age between 50 and 90 years A score of 20 or more on the Mini Mental State Examination (MMSE) Imaging (CT or MR of cerebrum) consistent with AD Have a caregiver with regular contact to the participant (more than once a month) who is also willing to participate in the study In general good health allowing the participant to participate in physical exercise. At least 7 years of schooling and Danish speaking Visual acuity and hearing must permit neuropsychological testing. If the patient is receiving anti-dementia medication or mood stabilizing medication, these must have been given in stable doses for at least 3 months. Exclusion Criteria: Participation in aerobic exercise (moderate to hard intensity) more than 2 times a week on a regular basis. Any musculoskeletal or joint impairment that could interfere with completion of the study (significant joint problems, back pain or pain in arms and legs that provide problems with mobility in daily activities) Male participants with a combination of two or more of the following risk factors even if asymptomatic: smokers, hypertension and hypercholesterolemia Major neurologic (other than AD), cardiac or other medical diseases that constitutes a contraindication to physical activity. Stent operation or previous myocardial infarction is not an exclusion criteria if the participant has had a recent (within 3 months) normal exercise tests . Severe cerebro vascular disease judged from the CT or MR scans and remarkable hypertension defined as Systolic blood pressure >180 and diastolic >100 Severe psychiatric disease, as well as alcohol or drug abuse within the last 2 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steen G Hasselbalch, Professor
Organizational Affiliation
Memory Disorders Research Group, Department of Neurology, Copenhagen University Hospital, Rigshospitalet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Danish Dementia Research Centre, Department of Neurology, Rigshospitalet.
City
Copenhagen
State/Province
Copenhagen Ø
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
35249488
Citation
Musaeus CS, Johansen LB, Hasselbalch S, Beyer N, Hogh P, Siebner HR, Frederiksen KS. Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer's Disease. Curr Alzheimer Res. 2022;19(2):171-177. doi: 10.2174/1567205019666220304091241.
Results Reference
derived
PubMed Identifier
33246408
Citation
Clemmensen FK, Hoffmann K, Siersma V, Sobol N, Beyer N, Andersen BB, Vogel A, Lolk A, Gottrup H, Hogh P, Waldemar G, Hasselbalch SG, Frederiksen KS. The role of physical and cognitive function in performance of activities of daily living in patients with mild-to-moderate Alzheimer's disease - a cross-sectional study. BMC Geriatr. 2020 Nov 27;20(1):513. doi: 10.1186/s12877-020-01926-9.
Results Reference
derived
PubMed Identifier
30319397
Citation
Frederiksen KS, Larsen CT, Hasselbalch SG, Christensen AN, Hogh P, Wermuth L, Andersen BB, Siebner HR, Garde E. A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer's Disease. Front Aging Neurosci. 2018 Sep 25;10:293. doi: 10.3389/fnagi.2018.00293. eCollection 2018.
Results Reference
derived
PubMed Identifier
28615271
Citation
Sopina E, Sorensen J, Beyer N, Hasselbalch SG, Waldemar G. Cost-effectiveness of a randomised trial of physical activity in Alzheimer's disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark. BMJ Open. 2017 Jun 14;7(6):e015217. doi: 10.1136/bmjopen-2016-015217.
Results Reference
derived

Learn more about this trial

Effect of Physical Exercise in Alzheimer Patients

We'll reach out to this number within 24 hrs